PHARMACY

Revenue, profit rise for Watson in Q2

BY Alaric DeArment

MORRISTOWN, N.J. Generic drug maker Watson Pharmaceuticals posted strong sales for second quarter 2010, according to an earnings report.

Revenue for the quarter were $875.3 million, a 29% increase over second quarter 2009. Profit was $102.8 million, a 22% increase over last year.

“The second quarter was one of solid financial growth, consistent performance and continued progress against the strategies that will ensure growth of Watson’s global business,” Watson president and CEO Paul Bisaro said. “We continue to emphasize growing our businesses through product development and portfolio and market expansion.”

Generic drugs had global sales of $560.8 million, compared with $393.8 million in second quarter 2009. For the first six months of the year, generics sales were $1.09 billion, compared with $789 million during the same period last year.

Sales for Watson’s branded drugs segment were $76.9 million, compared with $97.6 million in second quarter 2009. The decrease was due mostly to Watson handing over marketing rights for the iron deficiency drug Ferrlecit (sodium ferric gluconate) to French drug maker Sanofi-Aventis in December.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

PositiveID files patent for Insulin Tracker

BY Alaric DeArment

DELRAY BEACH, Fla. A company that develops healthcare and information management products has applied for a patent for an insulin-pen tracking and recording device.

 

PositiveID announced Monday that it had filed for a patent for the Insulin Tracker with the U.S. Patent and Trademark Office. The device slides onto insulin pens and allows diabetes patients to track and record the amount of insulin they inject, including the time and date of each injection, transmitting it to PositiveID’s iGlucose System database and allowing patients and their healthcare providers to monitor compliance.

 

 

“Due to the cumbersome nature of manually recording blood glucose levels, insulin dosages and the appropriate dates and times for each, many patients’ diabetes logs are incomplete or even nonexistent, which directly impacts patient compliance,” PositiveID chairman and CEO Scott Silverman said.

 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

PHARMACY

Milwaukee Health Services taps new corporate communications specialist

BY Antoinette Alexander

MILWAUKEE, Wis. Milwaukee Health Services, which owns and operates a retail-based convenient care clinic here, has hired Clarene Mitchell as corporate communications specialist.

In her new role, Mitchell’s duties will include advancing the organization’s public image, facilitating business and government partnerships, fundraising strategy efforts and special projects.

An initial area of concentration will focus on increasing the public image and utilization of MHSI’s Convenient Care Clinic that operates in the Midtown Piggly Wiggly supermarket. MHSI opened the clinic in October 2009 in partnership with Managed Health Services. The clinic, which is owned and operated by MHSI, was the first retail based clinic to be opened by a Federally Qualified Health Center on a national basis, the company stated.

Mitchell most recently worked with VITAS Innovative Hospice Care. Her professional history includes managing programs and public relations interests for Black Health Coalition of Wisconsin.  Prior to that she was a health communications officer for the Milwaukee Health Department, the health and education liaison for Mayor John O. Norquist, in addition to other roles with such organizations as Sojourner Truth House, American Lung Association, Lisbon Avenue Neighborhood Development and the Milwaukee Urban League.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES